Skin Cancer of the Head and Neck · Prognosis & follow-up

What is the prognosis for skin cancer of the head and neck?

Reviewed: 8 November 2026 By: Xiangpeng Liu, MD Topic: Skin Cancer of the Head and Neck Answer length: short, citable
Quick answer

Localised basal cell carcinoma is almost always curable, and thin localised melanoma has five-year survival commonly above 90%. Prognosis worsens with thick or ulcerated melanoma, nodal metastasis, head and neck cSCC with perineural invasion, and immunosuppression. Because UV damage is field-wide, new primary skin cancers are common and long-term surveillance is essential.

In detail

Published survival figures are population averages from registry data. Your own outlook depends on stage, HPV or EBV status, margins, nodal involvement, general health, smoking status during treatment and response to the first treatment.

Most recurrences occur within the first two to five years. Follow-up visits are frequent at first (every one to three months in year one) and become annual after year five, in line with NCCN survivorship guidance.

What this means in practice: this answer is part of the “Prognosis & follow-up” section of the Skin Cancer of the Head and Neck topic. If you are comparing treatment options, also read how to compare a second opinion and which records to send.

Other common questions about skin cancer of the head and neck

See all 14 questions in this topic →

Sources for this answer

  1. NCCN Guidelines for Patients: Head and Neck Cancers National Comprehensive Cancer Network · 2025
  2. Global Cancer Facts & Figures, 5th Edition (GLOBOCAN 2022 tables) American Cancer Society · 2024
  3. Ultraviolet radiation and skin cancer (fact sheet) World Health Organization · 2024
  4. Global Cancer Observatory (GLOBOCAN 2022) International Agency for Research on Cancer / WHO · 2022 · Source of worldwide and country-level incidence and mortality estimates.
  5. NCCN Guidelines for Patients: Head and Neck Cancers National Comprehensive Cancer Network · 2025

Written and medically reviewed by Xiangpeng Liu, MD

Associate Chief Physician, ENT & Head/Neck Surgery · Chenzhou First People’s Hospital, Chenzhou, Hunan, China

Editorial policy & reviewer credentials · All sources

Need an opinion on your own case?

International patients can request a preliminary review based on pathology and imaging before travelling to China.

How the pathway works Send an enquiry

Medical disclaimer: This knowledge base is general information for people researching head and neck tumours, not a diagnosis or treatment plan. It does not replace an examination by a qualified physician. Survival figures are population averages, not predictions for an individual. Treatment and cost estimates for China are illustrative only and must be confirmed in writing after your records have been reviewed. If you have a symptom lasting more than two to three weeks, see a doctor promptly.